We next assessed in a dietary model of NASH (a high-fat choline-deficient (HFCD) diet) that causes macrovesicular steatosis, fibrosis, and inflammation23 the effect of CTSB inhibition. The gene discussed is CTSB; the disease is metabolic dysfunction-associated steatohepatitis.